News

MSG Networks in talks to avoid bankruptcy — possibly with help of Amazon: sources

MSG Networks, the embattled cable TV station that airs New York Knicks and Rangers games, is in talks to reach a deal to avoid bankruptcy as soon as Friday.

01/31/2025

Timber Pharmaceuticals, Inc., a LEO Pharma Company, Presents Late-Breaking Preliminary Results of TMB-001 in Moderate-to-Severe Congenital Ichthyosis (CI) at the 2024 AAD Annual Meeting

MADISON, N.J.--(BUSINESS WIRE)--Timber Pharmaceuticals, Inc., a LEO Pharma Comp., Presents Late-Breaking Preliminary Results of TMB-001 in Moderate-to-Severe Congenital Ichthyosis CI.

03/10/2024

Profitability

Dividends

Income Statement

Balance Sheet

Cash Flow Statement

Symbol Frequently Asked Questions

Is Timber Pharmaceuticals, Inc. (TMBR) a buy, sell, or hold?

Timber Pharmaceuticals, Inc. (TMBR) can hold. Click on Rating Page for detail.

What is Timber Pharmaceuticals, Inc.'s stock price?

The price of Timber Pharmaceuticals, Inc. (TMBR) is 0.3426 and it was updated on 2025-05-11 07:01:40.

Is Timber Pharmaceuticals, Inc. (TMBR) overvalued or undervalued?

Currently Timber Pharmaceuticals, Inc. (TMBR) is in undervalued.

News

From:

To:

News
LEO Pharma Finalizes Acquisition of Key Assets From Timber Pharmaceuticals BALLERUP, Denmark--(BUSINESS WIRE)--LEO Pharma today announced that it has finalized the acquisition of the strategic asset TMB-001 as well as certain other assets from Timber Pharmaceuticals following its chapter 11 bankruptcy filing. The TMB-001 project aims to develop a topical treatment for multiple moderate to severe subtypes of congenital ichthyosis – a skin disease with significant unmet need and no approved prescription therapies available. The TMB-001 project continues as planned and w. Tue, Jan. 23, 2024
Timber Pharmaceuticals Announces Commencement of NYSE American Delisting Proceedings: Common Stock Expected to Begin Trading on the OTC Market WARREN, N.J., Nov. 29, 2023 — Timber Pharmaceuticals, Inc. Wed, Nov. 29, 2023
Timber Pharmaceuticals Announces Commencement of NYSE American Delisting Proceedings: Common Stock Expected to Begin Trading on the OTC Market WARREN, N.J., Nov. 29, 2023 (GLOBE NEWSWIRE) -- Timber Pharmaceuticals, Inc. ("Timber" or the "Company") (NYSE American: TMBR), a clinical-stage biopharmaceutical company focused on the development and commercialization of treatments for rare and orphan dermatologic diseases, today announced that the staff of NYSE Regulation (the “NYSE Regulation”) has determined to immediately suspend trading in the Company's common stock from NYSE American, LLC (the “NYSE American”). Wed, Nov. 29, 2023
Timber Pharmaceuticals Receives Court Approval of All “First Day” Motions to Support Business Operations & Discloses Communication From NYSE American WARREN, NJ, Nov. 28, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Timber Pharmaceuticals, Inc. (NYSE American: TMBR), a clinical-stage biopharmaceutical company focused on the development and commercialization of treatments for rare and orphan dermatologic diseases, and its affiliated debtors and debtor-in-possession ("Timber" or the "Company"), today announced that all "first day" motions related to the Company's voluntary Chapter 11 petitions for reorganization filed on November 17, 2023, were approved on an interim basis by the U.S. Bankruptcy Court for the District of Delaware. Tue, Nov. 28, 2023
NYSE American to Commence Delisting Proceedings Against Timber Pharmaceuticals, Inc. (TMBR) NEW YORK--(BUSINESS WIRE)--NYSE American LLC (“NYSE American” or the “Exchange”) announced today that the staff of NYSE Regulation has determined to commence proceedings to delist the common stock of Timber Pharmaceuticals, Inc. (the “Company”) — ticker symbol TMBR — from NYSE American. NYSE Regulation has determined that the Company is no longer suitable for listing and will commence delisting proceedings pursuant to Section 1003(c)(iii) of the NYSE American Company Guide in light of the Compa. Tue, Nov. 21, 2023

SEC Filings

SEC Filings
Timber Pharmaceuticals, Inc. (TMBR) - 8-K - Current report SEC Filings 02/22/2024
Timber Pharmaceuticals, Inc. (TMBR) - 8-K - Current report SEC Filings 01/26/2024
Timber Pharmaceuticals, Inc. (TMBR) - 8-K - Current report SEC Filings 01/23/2024
Timber Pharmaceuticals, Inc. (TMBR) - 8-K - Current report SEC Filings 12/22/2023
Timber Pharmaceuticals, Inc. (TMBR) - 25-NSE SEC Filings 11/29/2023
Timber Pharmaceuticals, Inc. (TMBR) - 8-K - Current report SEC Filings 11/28/2023
Timber Pharmaceuticals, Inc. (TMBR) - 8-K - Current report SEC Filings 11/17/2023
Timber Pharmaceuticals, Inc. (TMBR) - NT 10-Q - Quarterly Report SEC Filings 11/15/2023
Timber Pharmaceuticals, Inc. (TMBR) - DEFA14A SEC Filings 10/31/2023
Timber Pharmaceuticals, Inc. (TMBR) - 8-K - Current report SEC Filings 10/30/2023
Timber Pharmaceuticals, Inc. (TMBR) - 425 SEC Filings 10/30/2023
Timber Pharmaceuticals, Inc. (TMBR) - 8-K - Current report SEC Filings 10/16/2023
Timber Pharmaceuticals, Inc. (TMBR) - 425 SEC Filings 10/16/2023
Timber Pharmaceuticals, Inc. (TMBR) - 8-K - Current report SEC Filings 09/18/2023
Timber Pharmaceuticals, Inc. (TMBR) - PRER14A SEC Filings 09/12/2023
Timber Pharmaceuticals, Inc. (TMBR) - DEFM14A SEC Filings 09/12/2023
Timber Pharmaceuticals, Inc. (TMBR) - PREM14A SEC Filings 09/01/2023
Timber Pharmaceuticals, Inc. (TMBR) - DEFA14A SEC Filings 08/31/2023
Timber Pharmaceuticals, Inc. (TMBR) - 8-K - Current report SEC Filings 08/31/2023
Timber Pharmaceuticals, Inc. (TMBR) - 4 SEC Filings 08/22/2023
Timber Pharmaceuticals, Inc. (TMBR) - DEFA14A SEC Filings 08/21/2023
Timber Pharmaceuticals, Inc. (TMBR) - 8-K - Current report SEC Filings 08/21/2023
Timber Pharmaceuticals, Inc. (TMBR) - 10-Q - Quarterly Report SEC Filings 08/21/2023
Timber Pharmaceuticals, Inc. (TMBR) - NT 10-Q - Quarterly Report SEC Filings 08/14/2023
Timber Pharmaceuticals, Inc. (TMBR) - S-8 SEC Filings 08/02/2023
Timber Pharmaceuticals, Inc. (TMBR) - 8-K - Current report SEC Filings 07/03/2023
Timber Pharmaceuticals, Inc. (TMBR) - 8-K - Current report SEC Filings 06/29/2023
Timber Pharmaceuticals, Inc. (TMBR) - 8-K - Current report SEC Filings 06/23/2023
Timber Pharmaceuticals, Inc. (TMBR) - 8-K - Current report SEC Filings 06/20/2023
Timber Pharmaceuticals, Inc. (TMBR) - 8-K - Current report SEC Filings 06/05/2023
Timber Pharmaceuticals, Inc. (TMBR) - 8-K - Current report SEC Filings 06/02/2023
Timber Pharmaceuticals, Inc. (TMBR) - 8-K - Current report SEC Filings 05/15/2023
Timber Pharmaceuticals, Inc. (TMBR) - 10-Q - Quarterly Report SEC Filings 05/15/2023
Timber Pharmaceuticals, Inc. (TMBR) - DEF 14A SEC Filings 05/01/2023
Timber Pharmaceuticals, Inc. (TMBR) - ARS SEC Filings 05/01/2023
Timber Pharmaceuticals, Inc. (TMBR) - 4 SEC Filings 04/18/2023
Timber Pharmaceuticals, Inc. (TMBR) - 8-K - Current report SEC Filings 03/31/2023
Timber Pharmaceuticals, Inc. (TMBR) - 10-K - Current report SEC Filings 03/31/2023
Timber Pharmaceuticals, Inc. (TMBR) - 8-K - Current report SEC Filings 02/03/2023
Timber Pharmaceuticals, Inc. (TMBR) - 4 SEC Filings 12/16/2022
Timber Pharmaceuticals, Inc. (TMBR) - 8-K - Current report SEC Filings 12/14/2022
Timber Pharmaceuticals, Inc. (TMBR) - 8-K - Current report SEC Filings 12/09/2022
Timber Pharmaceuticals, Inc. (TMBR) - 8-K - Current report SEC Filings 11/14/2022
Timber Pharmaceuticals, Inc. (TMBR) - 10-Q - Quarterly Report SEC Filings 11/14/2022
Timber Pharmaceuticals, Inc. (TMBR) - 8-K - Current report SEC Filings 11/09/2022
Timber Pharmaceuticals, Inc. (TMBR) - 8-K - Current report SEC Filings 11/08/2022
Timber Pharmaceuticals, Inc. (TMBR) - 8-K - Current report SEC Filings 11/03/2022
Timber Pharmaceuticals, Inc. (TMBR) - 8-K - Current report SEC Filings 10/25/2022
Timber Pharmaceuticals, Inc. (TMBR) - DEF 14A SEC Filings 10/17/2022
Timber Pharmaceuticals, Inc. (TMBR) - D SEC Filings 10/11/2022
Timber Pharmaceuticals, Inc. (TMBR) - PRE 14A SEC Filings 10/05/2022
Timber Pharmaceuticals, Inc. (TMBR) - 8-K - Current report SEC Filings 10/03/2022
Timber Pharmaceuticals, Inc. (TMBR) - 424B5 SEC Filings 10/03/2022
Timber Pharmaceuticals, Inc. (TMBR) - 8-K - Current report SEC Filings 09/12/2022
Timber Pharmaceuticals, Inc. (TMBR) - 8-K - Current report SEC Filings 09/02/2022
Timber Pharmaceuticals, Inc. (TMBR) - 8-K - Current report SEC Filings 08/29/2022
Timber Pharmaceuticals, Inc. (TMBR) - SC 13G SEC Filings 08/15/2022
Timber Pharmaceuticals, Inc. (TMBR) - 8-K - Current report SEC Filings 08/12/2022
Timber Pharmaceuticals, Inc. (TMBR) - 10-Q - Quarterly Report SEC Filings 08/11/2022
Timber Pharmaceuticals, Inc. (TMBR) - 8-K - Current report SEC Filings 08/08/2022
Timber Pharmaceuticals, Inc. (TMBR) - EFFECT SEC Filings 08/05/2022
Timber Pharmaceuticals, Inc. (TMBR) - EFFECT SEC Filings 08/05/2022
Timber Pharmaceuticals, Inc. (TMBR) - 424B4 SEC Filings 08/05/2022
Timber Pharmaceuticals, Inc. (TMBR) - CORRESP SEC Filings 08/03/2022
Timber Pharmaceuticals, Inc. (TMBR) - S-1/A SEC Filings 08/02/2022
Timber Pharmaceuticals, Inc. (TMBR) - 8-K - Current report SEC Filings 08/02/2022
Timber Pharmaceuticals, Inc. (TMBR) - 8-K - Current report SEC Filings 08/01/2022
Timber Pharmaceuticals, Inc. (TMBR) - 8-K - Current report SEC Filings 07/26/2022
Timber Pharmaceuticals, Inc. (TMBR) - UPLOAD SEC Filings 07/06/2022
Timber Pharmaceuticals, Inc. (TMBR) - S-1 SEC Filings 07/01/2022
Timber Pharmaceuticals, Inc. (TMBR) - 8-K - Current report SEC Filings 06/23/2022
Timber Pharmaceuticals, Inc. (TMBR) - 8-K - Current report SEC Filings 06/10/2022
Timber Pharmaceuticals, Inc. (TMBR) - 8-K - Current report SEC Filings 06/07/2022
Timber Pharmaceuticals, Inc. (TMBR) - 8-K - Current report SEC Filings 05/31/2022
Timber Pharmaceuticals, Inc. (TMBR) - 8-K - Current report SEC Filings 05/12/2022
Timber Pharmaceuticals, Inc. (TMBR) - 10-Q - Quarterly Report SEC Filings 05/12/2022
Timber Pharmaceuticals, Inc. (TMBR) - 8-K - Current report SEC Filings 04/28/2022
Timber Pharmaceuticals, Inc. (TMBR) - 8-K - Current report SEC Filings 04/25/2022
Timber Pharmaceuticals, Inc. (TMBR) - DEFA14A SEC Filings 04/22/2022
Timber Pharmaceuticals, Inc. (TMBR) - DEF 14A SEC Filings 04/22/2022
Timber Pharmaceuticals, Inc. (TMBR) - 4 SEC Filings 04/19/2022
Timber Pharmaceuticals, Inc. (TMBR) - 4 SEC Filings 04/15/2022
Timber Pharmaceuticals, Inc. (TMBR) - PRE 14A SEC Filings 04/12/2022
Timber Pharmaceuticals, Inc. (TMBR) - 8-K - Current report SEC Filings 04/11/2022
Timber Pharmaceuticals, Inc. (TMBR) - 8-K - Current report SEC Filings 04/01/2022
Timber Pharmaceuticals, Inc. (TMBR) - 8-K - Current report SEC Filings 03/31/2022
Timber Pharmaceuticals, Inc. (TMBR) - 10-K - Current report SEC Filings 03/31/2022
Timber Pharmaceuticals, Inc. (TMBR) - 8-K - Current report SEC Filings 03/25/2022
Timber Pharmaceuticals, Inc. (TMBR) - SC 13G/A SEC Filings 02/14/2022
Timber Pharmaceuticals, Inc. (TMBR) - SC 13G/A SEC Filings 02/04/2022
Timber Pharmaceuticals, Inc. (TMBR) - 8-K - Current report SEC Filings 02/03/2022
Timber Pharmaceuticals, Inc. (TMBR) - S-8 SEC Filings 01/28/2022
Timber Pharmaceuticals, Inc. (TMBR) - SC 13G/A SEC Filings 01/18/2022
Timber Pharmaceuticals, Inc. (TMBR) - 8-K - Current report SEC Filings 01/18/2022
Timber Pharmaceuticals, Inc. (TMBR) - 4 SEC Filings 12/16/2021
Timber Pharmaceuticals, Inc. (TMBR) - 8-K - Current report SEC Filings 12/08/2021
Timber Pharmaceuticals, Inc. (TMBR) - 4 SEC Filings 11/24/2021
Timber Pharmaceuticals, Inc. (TMBR) - 8-K - Current report SEC Filings 11/22/2021
Timber Pharmaceuticals, Inc. (TMBR) - 8-K - Current report SEC Filings 11/15/2021
Timber Pharmaceuticals, Inc. (TMBR) - 10-Q - Quarterly Report SEC Filings 11/15/2021
Timber Pharmaceuticals, Inc. (TMBR) - 8-K - Current report SEC Filings 11/04/2021
Timber Pharmaceuticals, Inc. (TMBR) - 424B5 SEC Filings 11/04/2021
Timber Pharmaceuticals, Inc. (TMBR) - 424B5 SEC Filings 11/02/2021
Timber Pharmaceuticals, Inc. (TMBR) - 8-K - Current report SEC Filings 10/07/2021
Timber Pharmaceuticals, Inc. (TMBR) - 8-K - Current report SEC Filings 09/29/2021
Timber Pharmaceuticals, Inc. (TMBR) - 4 SEC Filings 09/29/2021
Timber Pharmaceuticals, Inc. (TMBR) - S-8 SEC Filings 09/27/2021
Timber Pharmaceuticals, Inc. (TMBR) - 8-K - Current report SEC Filings 09/16/2021
Timber Pharmaceuticals, Inc. (TMBR) - 4 SEC Filings 09/16/2021
Timber Pharmaceuticals, Inc. (TMBR) - 8-K - Current report SEC Filings 09/13/2021
Timber Pharmaceuticals, Inc. (TMBR) - SC 13D/A SEC Filings 09/09/2021
Timber Pharmaceuticals, Inc. (TMBR) - 4 SEC Filings 09/02/2021
Timber Pharmaceuticals, Inc. (TMBR) - SC 13D/A SEC Filings 09/01/2021
Timber Pharmaceuticals, Inc. (TMBR) - 4 SEC Filings 09/01/2021
Timber Pharmaceuticals, Inc. (TMBR) - SC 13D/A SEC Filings 08/27/2021
Timber Pharmaceuticals, Inc. (TMBR) - 4 SEC Filings 08/26/2021
Timber Pharmaceuticals, Inc. (TMBR) - 8-K - Current report SEC Filings 08/24/2021
Timber Pharmaceuticals, Inc. (TMBR) - 4 SEC Filings 08/20/2021
Timber Pharmaceuticals, Inc. (TMBR) - 8-K - Current report SEC Filings 08/10/2021
Timber Pharmaceuticals, Inc. (TMBR) - 10-Q - Quarterly Report SEC Filings 08/10/2021
Timber Pharmaceuticals, Inc. (TMBR) - 4 SEC Filings 07/06/2021
Timber Pharmaceuticals, Inc. (TMBR) - 8-K - Current report SEC Filings 07/02/2021
Timber Pharmaceuticals, Inc. (TMBR) - 8-K - Current report SEC Filings 07/01/2021
Timber Pharmaceuticals, Inc. (TMBR) - DEFA14A SEC Filings 06/23/2021
Timber Pharmaceuticals, Inc. (TMBR) - 4 SEC Filings 06/15/2021
Timber Pharmaceuticals, Inc. (TMBR) - SC 13D/A SEC Filings 06/11/2021
Timber Pharmaceuticals, Inc. (TMBR) - 4 SEC Filings 06/10/2021
Timber Pharmaceuticals, Inc. (TMBR) - DEFA14A SEC Filings 06/03/2021
Timber Pharmaceuticals, Inc. (TMBR) - 8-K - Current report SEC Filings 06/03/2021
Timber Pharmaceuticals, Inc. (TMBR) - 4 SEC Filings 06/02/2021
Timber Pharmaceuticals, Inc. (TMBR) - 8-K - Current report SEC Filings 05/26/2021
Timber Pharmaceuticals, Inc. (TMBR) - 424B3 SEC Filings 05/25/2021
Timber Pharmaceuticals, Inc. (TMBR) - 10-K/A - Current report SEC Filings 05/17/2021
Timber Pharmaceuticals, Inc. (TMBR) - 4 SEC Filings 05/13/2021
Timber Pharmaceuticals, Inc. (TMBR) - EFFECT SEC Filings 05/12/2021
Timber Pharmaceuticals, Inc. (TMBR) - EFFECT SEC Filings 05/12/2021
Timber Pharmaceuticals, Inc. (TMBR) - EFFECT SEC Filings 05/11/2021
Timber Pharmaceuticals, Inc. (TMBR) - 8-K - Current report SEC Filings 05/11/2021
Timber Pharmaceuticals, Inc. (TMBR) - 10-Q - Quarterly Report SEC Filings 05/11/2021
Timber Pharmaceuticals, Inc. (TMBR) - UPLOAD SEC Filings 05/07/2021
Timber Pharmaceuticals, Inc. (TMBR) - CORRESP SEC Filings 05/07/2021
Timber Pharmaceuticals, Inc. (TMBR) - S-3 SEC Filings 05/04/2021
Timber Pharmaceuticals, Inc. (TMBR) - DEFA14A SEC Filings 04/29/2021
Timber Pharmaceuticals, Inc. (TMBR) - 8-K - Current report SEC Filings 04/28/2021
Timber Pharmaceuticals, Inc. (TMBR) - DEFA14A SEC Filings 04/23/2021
Timber Pharmaceuticals, Inc. (TMBR) - DEF 14A SEC Filings 04/23/2021
Timber Pharmaceuticals, Inc. (TMBR) - 8-K - Current report SEC Filings 04/23/2021
Timber Pharmaceuticals, Inc. (TMBR) - 8-K - Current report SEC Filings 04/16/2021
Timber Pharmaceuticals, Inc. (TMBR) - 8-K - Current report SEC Filings 03/23/2021
Timber Pharmaceuticals, Inc. (TMBR) - 10-K - Current report SEC Filings 03/23/2021
Timber Pharmaceuticals, Inc. (TMBR) - 8-K - Current report SEC Filings 03/17/2021
Timber Pharmaceuticals, Inc. (TMBR) - 8-K - Current report SEC Filings 03/16/2021
Timber Pharmaceuticals, Inc. (TMBR) - SC 13G/A SEC Filings 02/16/2021
Timber Pharmaceuticals, Inc. (TMBR) - SC 13G SEC Filings 02/11/2021
Timber Pharmaceuticals, Inc. (TMBR) - 8-K - Current report SEC Filings 02/04/2021
Timber Pharmaceuticals, Inc. (TMBR) - 3 SEC Filings 02/04/2021
Timber Pharmaceuticals, Inc. (TMBR) - SC 13G/A SEC Filings 01/28/2021
Timber Pharmaceuticals, Inc. (TMBR) - 8-K - Current report SEC Filings 01/25/2021
Timber Pharmaceuticals, Inc. (TMBR) - 8-K - Current report SEC Filings 01/13/2021
Timber Pharmaceuticals, Inc. (TMBR) - 8-K - Current report SEC Filings 01/12/2021
Timber Pharmaceuticals, Inc. (TMBR) - 8-K - Current report SEC Filings 12/17/2020
Timber Pharmaceuticals, Inc. (TMBR) - EFFECT SEC Filings 12/11/2020
Timber Pharmaceuticals, Inc. (TMBR) - 424B3 SEC Filings 12/11/2020
Timber Pharmaceuticals, Inc. (TMBR) - EFFECT SEC Filings 12/10/2020
Timber Pharmaceuticals, Inc. (TMBR) - 424B3 SEC Filings 12/10/2020
Timber Pharmaceuticals, Inc. (TMBR) - S-3 SEC Filings 12/04/2020
Timber Pharmaceuticals, Inc. (TMBR) - 8-K - Current report SEC Filings 11/20/2020
Timber Pharmaceuticals, Inc. (TMBR) - 8-K - Current report SEC Filings 11/12/2020
Timber Pharmaceuticals, Inc. (TMBR) - 10-Q - Quarterly Report SEC Filings 11/12/2020
Timber Pharmaceuticals, Inc. (TMBR) - SC 13D/A SEC Filings 09/24/2020
Timber Pharmaceuticals, Inc. (TMBR) - 8-K - Current report SEC Filings 09/16/2020
Timber Pharmaceuticals, Inc. (TMBR) - 4 SEC Filings 09/16/2020
Timber Pharmaceuticals, Inc. (TMBR) - 4 SEC Filings 09/14/2020
Timber Pharmaceuticals, Inc. (TMBR) - 3 SEC Filings 08/26/2020
Timber Pharmaceuticals, Inc. (TMBR) - 3 SEC Filings 08/25/2020
Timber Pharmaceuticals, Inc. (TMBR) - 8-K - Current report SEC Filings 08/19/2020
Timber Pharmaceuticals, Inc. (TMBR) - 8-K - Current report SEC Filings 08/18/2020
Timber Pharmaceuticals, Inc. (TMBR) - 10-Q - Quarterly Report SEC Filings 08/18/2020
Timber Pharmaceuticals, Inc. (TMBR) - NT 10-Q - Quarterly Report SEC Filings 08/17/2020
Timber Pharmaceuticals, Inc. (TMBR) - 8-K/A - Current report SEC Filings 07/02/2020
Timber Pharmaceuticals, Inc. (TMBR) - S-8 SEC Filings 06/16/2020
Timber Pharmaceuticals, Inc. (TMBR) - 10-Q - Quarterly Report SEC Filings 06/12/2020
Timber Pharmaceuticals, Inc. (TMBR) - 4 SEC Filings 06/09/2020
Timber Pharmaceuticals, Inc. (TMBR) - 3 SEC Filings 06/09/2020
Timber Pharmaceuticals, Inc. (TMBR) - 8-K - Current report SEC Filings 06/03/2020
Timber Pharmaceuticals, Inc. (TMBR) - SC 13G SEC Filings 05/29/2020
Timber Pharmaceuticals, Inc. (TMBR) - SC 13D/A SEC Filings 05/28/2020
Timber Pharmaceuticals, Inc. (TMBR) - SC 13G SEC Filings 05/27/2020
Timber Pharmaceuticals, Inc. (TMBR) - 8-K - Current report SEC Filings 05/22/2020
Timber Pharmaceuticals, Inc. (TMBR) - 4 SEC Filings 05/20/2020
Timber Pharmaceuticals, Inc. (TMBR) - 3 SEC Filings 05/20/2020
Timber Pharmaceuticals, Inc. (TMBR) - 8-K - Current report SEC Filings 05/15/2020
Timber Pharmaceuticals, Inc. (TMBR) - 8-K - Current report SEC Filings 05/13/2020
Timber Pharmaceuticals, Inc. (TMBR) - 425 SEC Filings 05/13/2020
Timber Pharmaceuticals, Inc. (TMBR) - 8-K - Current report SEC Filings 05/11/2020
Timber Pharmaceuticals, Inc. (TMBR) - 425 SEC Filings 05/11/2020
Timber Pharmaceuticals, Inc. (TMBR) - 425 SEC Filings 05/07/2020
Timber Pharmaceuticals, Inc. (TMBR) - DEFA14A SEC Filings 04/27/2020
Timber Pharmaceuticals, Inc. (TMBR) - 8-K - Current report SEC Filings 04/27/2020
Timber Pharmaceuticals, Inc. (TMBR) - 425 SEC Filings 04/27/2020
Timber Pharmaceuticals, Inc. (TMBR) - 8-K - Current report SEC Filings 04/06/2020
Timber Pharmaceuticals, Inc. (TMBR) - 425 SEC Filings 04/06/2020
Timber Pharmaceuticals, Inc. (TMBR) - EFFECT SEC Filings 04/01/2020
Timber Pharmaceuticals, Inc. (TMBR) - 424B3 SEC Filings 04/01/2020
Timber Pharmaceuticals, Inc. (TMBR) - S-4/A SEC Filings 03/30/2020
Timber Pharmaceuticals, Inc. (TMBR) - CORRESP SEC Filings 03/30/2020
Timber Pharmaceuticals, Inc. (TMBR) - 8-K - Current report SEC Filings 03/30/2020
Timber Pharmaceuticals, Inc. (TMBR) - 425 SEC Filings 03/30/2020
Timber Pharmaceuticals, Inc. (TMBR) - 10-K - Current report SEC Filings 03/23/2020
Timber Pharmaceuticals, Inc. (TMBR) - UPLOAD SEC Filings 02/25/2020
Timber Pharmaceuticals, Inc. (TMBR) - S-4 SEC Filings 02/20/2020
Timber Pharmaceuticals, Inc. (TMBR) - 8-K - Current report SEC Filings 02/18/2020
Timber Pharmaceuticals, Inc. (TMBR) - SC 13G/A SEC Filings 02/13/2020
Timber Pharmaceuticals, Inc. (TMBR) - 4 SEC Filings 02/12/2020
Timber Pharmaceuticals, Inc. (TMBR) - 8-K - Current report SEC Filings 02/03/2020
Timber Pharmaceuticals, Inc. (TMBR) - SC 13D SEC Filings 01/30/2020
Timber Pharmaceuticals, Inc. (TMBR) - 3 SEC Filings 01/30/2020
Timber Pharmaceuticals, Inc. (TMBR) - 8-K - Current report SEC Filings 01/29/2020
Timber Pharmaceuticals, Inc. (TMBR) - 425 SEC Filings 01/29/2020
Timber Pharmaceuticals, Inc. (TMBR) - SC 13G/A SEC Filings 01/15/2020
Timber Pharmaceuticals, Inc. (TMBR) - 8-K - Current report SEC Filings 12/10/2019
Timber Pharmaceuticals, Inc. (TMBR) - 10-Q - Quarterly Report SEC Filings 12/10/2019
Timber Pharmaceuticals, Inc. (TMBR) - 8-K - Current report SEC Filings 09/20/2019
Timber Pharmaceuticals, Inc. (TMBR) - 8-K - Current report SEC Filings 09/09/2019
Timber Pharmaceuticals, Inc. (TMBR) - 10-Q - Quarterly Report SEC Filings 09/09/2019
Timber Pharmaceuticals, Inc. (TMBR) - 4 SEC Filings 07/18/2019
Timber Pharmaceuticals, Inc. (TMBR) - 3 SEC Filings 07/18/2019
Timber Pharmaceuticals, Inc. (TMBR) - 8-K - Current report SEC Filings 07/17/2019
Timber Pharmaceuticals, Inc. (TMBR) - 8-K - Current report SEC Filings 07/11/2019
Timber Pharmaceuticals, Inc. (TMBR) - SC 13G/A SEC Filings 06/27/2019
Timber Pharmaceuticals, Inc. (TMBR) - 4 SEC Filings 06/27/2019
Timber Pharmaceuticals, Inc. (TMBR) - 8-K - Current report SEC Filings 06/25/2019
Timber Pharmaceuticals, Inc. (TMBR) - 4 SEC Filings 06/14/2019
Timber Pharmaceuticals, Inc. (TMBR) - 8-K - Current report SEC Filings 06/11/2019
Timber Pharmaceuticals, Inc. (TMBR) - 10-Q - Quarterly Report SEC Filings 06/11/2019
Timber Pharmaceuticals, Inc. (TMBR) - DEF 14A SEC Filings 05/22/2019
Timber Pharmaceuticals, Inc. (TMBR) - 8-K - Current report SEC Filings 05/16/2019
Timber Pharmaceuticals, Inc. (TMBR) - 424B5 SEC Filings 05/16/2019
Timber Pharmaceuticals, Inc. (TMBR) - 8-K - Current report SEC Filings 04/26/2019
Timber Pharmaceuticals, Inc. (TMBR) - 8-K - Current report SEC Filings 03/25/2019
Timber Pharmaceuticals, Inc. (TMBR) - 424B5 SEC Filings 03/22/2019
Timber Pharmaceuticals, Inc. (TMBR) - 8-K - Current report SEC Filings 03/21/2019
Timber Pharmaceuticals, Inc. (TMBR) - 8-K - Current report SEC Filings 03/14/2019
Timber Pharmaceuticals, Inc. (TMBR) - 10-K - Current report SEC Filings 03/14/2019
Timber Pharmaceuticals, Inc. (TMBR) - 8-K - Current report SEC Filings 02/27/2019
Timber Pharmaceuticals, Inc. (TMBR) - 4 SEC Filings 02/21/2019
Timber Pharmaceuticals, Inc. (TMBR) - 3 SEC Filings 02/21/2019
Timber Pharmaceuticals, Inc. (TMBR) - EFFECT SEC Filings 02/14/2019
Timber Pharmaceuticals, Inc. (TMBR) - SC 13G/A SEC Filings 02/14/2019
Timber Pharmaceuticals, Inc. (TMBR) - UPLOAD SEC Filings 02/11/2019
Timber Pharmaceuticals, Inc. (TMBR) - CORRESP SEC Filings 02/11/2019
Timber Pharmaceuticals, Inc. (TMBR) - 8-K - Current report SEC Filings 02/04/2019
Timber Pharmaceuticals, Inc. (TMBR) - S-3 SEC Filings 01/31/2019
Timber Pharmaceuticals, Inc. (TMBR) - SC 13G/A SEC Filings 01/29/2019
Timber Pharmaceuticals, Inc. (TMBR) - 4 SEC Filings 01/25/2019
Timber Pharmaceuticals, Inc. (TMBR) - 8-K - Current report SEC Filings 12/20/2018
Timber Pharmaceuticals, Inc. (TMBR) - SC 13D/A SEC Filings 12/07/2018
Timber Pharmaceuticals, Inc. (TMBR) - 10-Q - Quarterly Report SEC Filings 12/07/2018
Timber Pharmaceuticals, Inc. (TMBR) - 8-K - Current report SEC Filings 12/06/2018
Timber Pharmaceuticals, Inc. (TMBR) - 8-K - Current report SEC Filings 11/21/2018
Timber Pharmaceuticals, Inc. (TMBR) - SC 13D/A SEC Filings 11/02/2018
Timber Pharmaceuticals, Inc. (TMBR) - 8-K - Current report SEC Filings 11/02/2018
Timber Pharmaceuticals, Inc. (TMBR) - 8-K - Current report SEC Filings 10/31/2018
Timber Pharmaceuticals, Inc. (TMBR) - 4 SEC Filings 10/31/2018
Timber Pharmaceuticals, Inc. (TMBR) - 4 SEC Filings 10/22/2018
Timber Pharmaceuticals, Inc. (TMBR) - 4 SEC Filings 10/12/2018
Timber Pharmaceuticals, Inc. (TMBR) - 3 SEC Filings 10/12/2018
Timber Pharmaceuticals, Inc. (TMBR) - 8-K - Current report SEC Filings 10/11/2018
Timber Pharmaceuticals, Inc. (TMBR) - 8-K - Current report SEC Filings 09/28/2018
Timber Pharmaceuticals, Inc. (TMBR) - 4 SEC Filings 09/20/2018
Timber Pharmaceuticals, Inc. (TMBR) - 8-K - Current report SEC Filings 09/13/2018
Timber Pharmaceuticals, Inc. (TMBR) - 4 SEC Filings 09/13/2018
Timber Pharmaceuticals, Inc. (TMBR) - 3 SEC Filings 09/13/2018
Timber Pharmaceuticals, Inc. (TMBR) - 4 SEC Filings 09/11/2018
Timber Pharmaceuticals, Inc. (TMBR) - S-8 SEC Filings 09/10/2018
Timber Pharmaceuticals, Inc. (TMBR) - 10-Q - Quarterly Report SEC Filings 09/10/2018
Timber Pharmaceuticals, Inc. (TMBR) - 8-K - Current report SEC Filings 08/30/2018
Timber Pharmaceuticals, Inc. (TMBR) - 8-K - Current report SEC Filings 08/17/2018
Timber Pharmaceuticals, Inc. (TMBR) - DEF 14A SEC Filings 07/06/2018
Timber Pharmaceuticals, Inc. (TMBR) - PRE 14A SEC Filings 06/26/2018
Timber Pharmaceuticals, Inc. (TMBR) - 10-Q - Quarterly Report SEC Filings 06/08/2018
Timber Pharmaceuticals, Inc. (TMBR) - 8-K - Current report SEC Filings 06/07/2018
Timber Pharmaceuticals, Inc. (TMBR) - 8-K - Current report SEC Filings 04/26/2018
Timber Pharmaceuticals, Inc. (TMBR) - 10-K - Current report SEC Filings 04/26/2018
Timber Pharmaceuticals, Inc. (TMBR) - 8-K - Current report SEC Filings 03/13/2018
Timber Pharmaceuticals, Inc. (TMBR) - 8-K - Current report SEC Filings 03/09/2018
Timber Pharmaceuticals, Inc. (TMBR) - 4 SEC Filings 03/09/2018
Timber Pharmaceuticals, Inc. (TMBR) - SC 13G/A SEC Filings 02/14/2018
Timber Pharmaceuticals, Inc. (TMBR) - SC 13G/A SEC Filings 02/12/2018
Timber Pharmaceuticals, Inc. (TMBR) - 4 SEC Filings 01/31/2018
Timber Pharmaceuticals, Inc. (TMBR) - SC 13G/A SEC Filings 01/16/2018
Timber Pharmaceuticals, Inc. (TMBR) - 8-K - Current report SEC Filings 01/16/2018
Timber Pharmaceuticals, Inc. (TMBR) - 4 SEC Filings 01/09/2018
Timber Pharmaceuticals, Inc. (TMBR) - 4 SEC Filings 12/22/2017
Timber Pharmaceuticals, Inc. (TMBR) - 10-Q - Quarterly Report SEC Filings 12/12/2017
Timber Pharmaceuticals, Inc. (TMBR) - 8-K - Current report SEC Filings 12/07/2017
Timber Pharmaceuticals, Inc. (TMBR) - 8-K - Current report SEC Filings 12/01/2017
Timber Pharmaceuticals, Inc. (TMBR) - SC 13G SEC Filings 11/30/2017
Timber Pharmaceuticals, Inc. (TMBR) - 8-K - Current report SEC Filings 11/27/2017
Timber Pharmaceuticals, Inc. (TMBR) - 4 SEC Filings 11/27/2017
Timber Pharmaceuticals, Inc. (TMBR) - 424B4 SEC Filings 11/22/2017
Timber Pharmaceuticals, Inc. (TMBR) - EFFECT SEC Filings 11/21/2017
Timber Pharmaceuticals, Inc. (TMBR) - S-1MEF SEC Filings 11/20/2017
Timber Pharmaceuticals, Inc. (TMBR) - S-1/A SEC Filings 11/20/2017
Timber Pharmaceuticals, Inc. (TMBR) - S-1/A SEC Filings 11/17/2017
Timber Pharmaceuticals, Inc. (TMBR) - CORRESP SEC Filings 11/16/2017
Timber Pharmaceuticals, Inc. (TMBR) - 4 SEC Filings 11/13/2017
Timber Pharmaceuticals, Inc. (TMBR) - S-1/A SEC Filings 11/09/2017
Timber Pharmaceuticals, Inc. (TMBR) - CORRESP SEC Filings 11/09/2017
Timber Pharmaceuticals, Inc. (TMBR) - UPLOAD SEC Filings 10/31/2017
Timber Pharmaceuticals, Inc. (TMBR) - 8-K - Current report SEC Filings 10/23/2017
Timber Pharmaceuticals, Inc. (TMBR) - 424B3 SEC Filings 10/23/2017
Timber Pharmaceuticals, Inc. (TMBR) - S-1 SEC Filings 10/19/2017
Timber Pharmaceuticals, Inc. (TMBR) - 8-K - Current report SEC Filings 09/13/2017
Timber Pharmaceuticals, Inc. (TMBR) - 10-Q - Quarterly Report SEC Filings 09/13/2017
Timber Pharmaceuticals, Inc. (TMBR) - EFFECT SEC Filings 08/28/2017
Timber Pharmaceuticals, Inc. (TMBR) - UPLOAD SEC Filings 08/24/2017
Timber Pharmaceuticals, Inc. (TMBR) - CORRESP SEC Filings 08/24/2017
Timber Pharmaceuticals, Inc. (TMBR) - S-3 SEC Filings 08/17/2017
Timber Pharmaceuticals, Inc. (TMBR) - SC 13D/A SEC Filings 08/08/2017
Timber Pharmaceuticals, Inc. (TMBR) - 4 SEC Filings 08/03/2017
Timber Pharmaceuticals, Inc. (TMBR) - 8-K - Current report SEC Filings 07/24/2017
Timber Pharmaceuticals, Inc. (TMBR) - 424B5 SEC Filings 07/24/2017
Timber Pharmaceuticals, Inc. (TMBR) - 10-Q - Quarterly Report SEC Filings 06/14/2017
Timber Pharmaceuticals, Inc. (TMBR) - 8-K - Current report SEC Filings 06/13/2017
Timber Pharmaceuticals, Inc. (TMBR) - DEF 14A SEC Filings 06/05/2017
Timber Pharmaceuticals, Inc. (TMBR) - 8-K - Current report SEC Filings 06/01/2017
Timber Pharmaceuticals, Inc. (TMBR) - 8-K - Current report SEC Filings 05/03/2017
Timber Pharmaceuticals, Inc. (TMBR) - SC 13G SEC Filings 05/01/2017
Timber Pharmaceuticals, Inc. (TMBR) - 4 SEC Filings 05/01/2017
Timber Pharmaceuticals, Inc. (TMBR) - 424B5 SEC Filings 04/27/2017
Timber Pharmaceuticals, Inc. (TMBR) - 8-K - Current report SEC Filings 04/26/2017
Timber Pharmaceuticals, Inc. (TMBR) - S-8 SEC Filings 04/21/2017
Timber Pharmaceuticals, Inc. (TMBR) - 10-K - Current report SEC Filings 04/21/2017
Timber Pharmaceuticals, Inc. (TMBR) - 4 SEC Filings 04/19/2017
Timber Pharmaceuticals, Inc. (TMBR) - 8-K - Current report SEC Filings 03/29/2017
Timber Pharmaceuticals, Inc. (TMBR) - 8-K - Current report SEC Filings 03/23/2017
Timber Pharmaceuticals, Inc. (TMBR) - UPLOAD SEC Filings 02/22/2017
Timber Pharmaceuticals, Inc. (TMBR) - DEF 14A SEC Filings 02/22/2017
Timber Pharmaceuticals, Inc. (TMBR) - PRER14A SEC Filings 02/21/2017
Timber Pharmaceuticals, Inc. (TMBR) - 8-K - Current report SEC Filings 02/21/2017
Timber Pharmaceuticals, Inc. (TMBR) - CORRESP SEC Filings 02/17/2017
Timber Pharmaceuticals, Inc. (TMBR) - SC 13G/A SEC Filings 02/13/2017
Timber Pharmaceuticals, Inc. (TMBR) - PRE 14A SEC Filings 02/10/2017
Timber Pharmaceuticals, Inc. (TMBR) - SC 13G/A SEC Filings 01/31/2017
Timber Pharmaceuticals, Inc. (TMBR) - 8-K - Current report SEC Filings 01/23/2017
Timber Pharmaceuticals, Inc. (TMBR) - 4 SEC Filings 01/20/2017
Timber Pharmaceuticals, Inc. (TMBR) - 3 SEC Filings 01/20/2017
Timber Pharmaceuticals, Inc. (TMBR) - 8-K - Current report SEC Filings 12/19/2016
Timber Pharmaceuticals, Inc. (TMBR) - 8-K - Current report SEC Filings 12/13/2016
Timber Pharmaceuticals, Inc. (TMBR) - 10-Q - Quarterly Report SEC Filings 12/13/2016
Timber Pharmaceuticals, Inc. (TMBR) - 4 SEC Filings 12/12/2016
Timber Pharmaceuticals, Inc. (TMBR) - SC 13G SEC Filings 12/02/2016
Timber Pharmaceuticals, Inc. (TMBR) - 3 SEC Filings 12/02/2016
Timber Pharmaceuticals, Inc. (TMBR) - SC 13D/A SEC Filings 12/01/2016
Timber Pharmaceuticals, Inc. (TMBR) - SC 13G SEC Filings 11/30/2016
Timber Pharmaceuticals, Inc. (TMBR) - 4 SEC Filings 11/30/2016
Timber Pharmaceuticals, Inc. (TMBR) - 8-K - Current report SEC Filings 11/29/2016
Timber Pharmaceuticals, Inc. (TMBR) - 4/A SEC Filings 11/29/2016
Timber Pharmaceuticals, Inc. (TMBR) - 4 SEC Filings 11/29/2016
Timber Pharmaceuticals, Inc. (TMBR) - 424B1 SEC Filings 11/23/2016
Timber Pharmaceuticals, Inc. (TMBR) - EFFECT SEC Filings 11/22/2016
Timber Pharmaceuticals, Inc. (TMBR) - S-1MEF SEC Filings 11/22/2016
Timber Pharmaceuticals, Inc. (TMBR) - 8-K - Current report SEC Filings 11/22/2016
Timber Pharmaceuticals, Inc. (TMBR) - S-1/A SEC Filings 11/18/2016
Timber Pharmaceuticals, Inc. (TMBR) - CORRESP SEC Filings 11/18/2016
Timber Pharmaceuticals, Inc. (TMBR) - S-1/A SEC Filings 11/04/2016
Timber Pharmaceuticals, Inc. (TMBR) - UPLOAD SEC Filings 10/21/2016
Timber Pharmaceuticals, Inc. (TMBR) - S-1 SEC Filings 10/14/2016
Timber Pharmaceuticals, Inc. (TMBR) - D SEC Filings 10/07/2016
Timber Pharmaceuticals, Inc. (TMBR) - 8-K - Current report SEC Filings 10/07/2016
Timber Pharmaceuticals, Inc. (TMBR) - EFFECT SEC Filings 09/30/2016
Timber Pharmaceuticals, Inc. (TMBR) - CORRESP SEC Filings 09/28/2016
Timber Pharmaceuticals, Inc. (TMBR) - 8-K - Current report SEC Filings 09/27/2016
Timber Pharmaceuticals, Inc. (TMBR) - 424B5 SEC Filings 09/27/2016
Timber Pharmaceuticals, Inc. (TMBR) - S-3/A SEC Filings 09/26/2016
Timber Pharmaceuticals, Inc. (TMBR) - CORRESP SEC Filings 09/26/2016
Timber Pharmaceuticals, Inc. (TMBR) - UPLOAD SEC Filings 09/23/2016
Timber Pharmaceuticals, Inc. (TMBR) - 8-K - Current report SEC Filings 09/19/2016
Timber Pharmaceuticals, Inc. (TMBR) - 8-K - Current report SEC Filings 09/16/2016
Timber Pharmaceuticals, Inc. (TMBR) - S-8 SEC Filings 09/14/2016
Timber Pharmaceuticals, Inc. (TMBR) - S-3 SEC Filings 09/14/2016
Timber Pharmaceuticals, Inc. (TMBR) - 10-Q - Quarterly Report SEC Filings 09/14/2016
Timber Pharmaceuticals, Inc. (TMBR) - 8-K - Current report SEC Filings 09/12/2016
Timber Pharmaceuticals, Inc. (TMBR) - SC 13D/A SEC Filings 08/26/2016
Timber Pharmaceuticals, Inc. (TMBR) - 8-K - Current report SEC Filings 08/24/2016
Timber Pharmaceuticals, Inc. (TMBR) - 8-K - Current report SEC Filings 08/18/2016
Timber Pharmaceuticals, Inc. (TMBR) - 4 SEC Filings 08/16/2016
Timber Pharmaceuticals, Inc. (TMBR) - NO ACT SEC Filings 07/27/2016
Timber Pharmaceuticals, Inc. (TMBR) - 8-K - Current report SEC Filings 07/25/2016
Timber Pharmaceuticals, Inc. (TMBR) - 4 SEC Filings 07/25/2016
Timber Pharmaceuticals, Inc. (TMBR) - 8-K - Current report SEC Filings 07/06/2016
Timber Pharmaceuticals, Inc. (TMBR) - 4 SEC Filings 07/06/2016
Timber Pharmaceuticals, Inc. (TMBR) - EFFECT SEC Filings 06/30/2016
Timber Pharmaceuticals, Inc. (TMBR) - S-3/A SEC Filings 06/28/2016
Timber Pharmaceuticals, Inc. (TMBR) - CORRESP SEC Filings 06/28/2016
Timber Pharmaceuticals, Inc. (TMBR) - UPLOAD SEC Filings 06/24/2016
Timber Pharmaceuticals, Inc. (TMBR) - S-3 SEC Filings 06/14/2016
Timber Pharmaceuticals, Inc. (TMBR) - 8-K - Current report SEC Filings 06/14/2016
Timber Pharmaceuticals, Inc. (TMBR) - 4 SEC Filings 06/14/2016
Timber Pharmaceuticals, Inc. (TMBR) - 10-Q - Quarterly Report SEC Filings 06/14/2016
Timber Pharmaceuticals, Inc. (TMBR) - DEFR14A SEC Filings 06/01/2016
Timber Pharmaceuticals, Inc. (TMBR) - DEF 14A SEC Filings 05/31/2016
Timber Pharmaceuticals, Inc. (TMBR) - 8-K - Current report SEC Filings 05/12/2016
Timber Pharmaceuticals, Inc. (TMBR) - 10-K - Current report SEC Filings 05/02/2016
Timber Pharmaceuticals, Inc. (TMBR) - 8-K - Current report SEC Filings 04/26/2016
Timber Pharmaceuticals, Inc. (TMBR) - 8-K - Current report SEC Filings 04/01/2016
Timber Pharmaceuticals, Inc. (TMBR) - 4 SEC Filings 03/31/2016
Timber Pharmaceuticals, Inc. (TMBR) - 424B5 SEC Filings 03/30/2016
Timber Pharmaceuticals, Inc. (TMBR) - 8-K - Current report SEC Filings 03/29/2016
Timber Pharmaceuticals, Inc. (TMBR) - 8-K - Current report SEC Filings 03/28/2016
Timber Pharmaceuticals, Inc. (TMBR) - 424B5 SEC Filings 03/28/2016
Timber Pharmaceuticals, Inc. (TMBR) - 8-K - Current report SEC Filings 03/18/2016
Timber Pharmaceuticals, Inc. (TMBR) - SC 13G/A SEC Filings 02/17/2016
Timber Pharmaceuticals, Inc. (TMBR) - SC 13G/A SEC Filings 02/16/2016
Timber Pharmaceuticals, Inc. (TMBR) - EFFECT SEC Filings 02/05/2016
Timber Pharmaceuticals, Inc. (TMBR) - UPLOAD SEC Filings 02/02/2016
Timber Pharmaceuticals, Inc. (TMBR) - CORRESP SEC Filings 02/02/2016
Timber Pharmaceuticals, Inc. (TMBR) - 8-K - Current report SEC Filings 01/27/2016
Timber Pharmaceuticals, Inc. (TMBR) - 4 SEC Filings 01/27/2016
Timber Pharmaceuticals, Inc. (TMBR) - 3 SEC Filings 01/27/2016
Timber Pharmaceuticals, Inc. (TMBR) - S-3 SEC Filings 01/19/2016
Timber Pharmaceuticals, Inc. (TMBR) - 4 SEC Filings 01/15/2016
Timber Pharmaceuticals, Inc. (TMBR) - 4 SEC Filings 01/12/2016
Timber Pharmaceuticals, Inc. (TMBR) - 4 SEC Filings 01/11/2016
Timber Pharmaceuticals, Inc. (TMBR) - SC 13D SEC Filings 12/21/2015
Timber Pharmaceuticals, Inc. (TMBR) - 3 SEC Filings 12/21/2015
Timber Pharmaceuticals, Inc. (TMBR) - 10-Q - Quarterly Report SEC Filings 12/15/2015
Timber Pharmaceuticals, Inc. (TMBR) - 8-K - Current report SEC Filings 12/14/2015
Timber Pharmaceuticals, Inc. (TMBR) - 8-K - Current report SEC Filings 12/11/2015
Timber Pharmaceuticals, Inc. (TMBR) - 4 SEC Filings 10/15/2015
Timber Pharmaceuticals, Inc. (TMBR) - 4 SEC Filings 10/13/2015
Timber Pharmaceuticals, Inc. (TMBR) - 8-K - Current report SEC Filings 09/14/2015
Timber Pharmaceuticals, Inc. (TMBR) - 10-Q - Quarterly Report SEC Filings 09/14/2015
Timber Pharmaceuticals, Inc. (TMBR) - 8-K - Current report SEC Filings 08/12/2015
Timber Pharmaceuticals, Inc. (TMBR) - 4 SEC Filings 08/12/2015
Timber Pharmaceuticals, Inc. (TMBR) - 3 SEC Filings 08/12/2015
Timber Pharmaceuticals, Inc. (TMBR) - 4 SEC Filings 07/02/2015
Timber Pharmaceuticals, Inc. (TMBR) - 3/A SEC Filings 07/02/2015
Timber Pharmaceuticals, Inc. (TMBR) - CT ORDER SEC Filings 06/29/2015
Timber Pharmaceuticals, Inc. (TMBR) - 4 SEC Filings 06/29/2015
Timber Pharmaceuticals, Inc. (TMBR) - 8-K - Current report SEC Filings 06/26/2015
Timber Pharmaceuticals, Inc. (TMBR) - EFFECT SEC Filings 06/25/2015
Timber Pharmaceuticals, Inc. (TMBR) - FWP SEC Filings 06/25/2015
Timber Pharmaceuticals, Inc. (TMBR) - 424B4 SEC Filings 06/25/2015
Timber Pharmaceuticals, Inc. (TMBR) - S-1MEF SEC Filings 06/24/2015
Timber Pharmaceuticals, Inc. (TMBR) - S-1/A SEC Filings 06/22/2015
Timber Pharmaceuticals, Inc. (TMBR) - CORRESP SEC Filings 06/22/2015
Timber Pharmaceuticals, Inc. (TMBR) - 8-K - Current report SEC Filings 06/19/2015
Timber Pharmaceuticals, Inc. (TMBR) - S-1/A SEC Filings 06/16/2015
Timber Pharmaceuticals, Inc. (TMBR) - CORRESP SEC Filings 06/12/2015
Timber Pharmaceuticals, Inc. (TMBR) - 10-Q - Quarterly Report SEC Filings 06/12/2015
Timber Pharmaceuticals, Inc. (TMBR) - S-1/A SEC Filings 06/08/2015
Timber Pharmaceuticals, Inc. (TMBR) - CORRESP SEC Filings 06/08/2015
Timber Pharmaceuticals, Inc. (TMBR) - UPLOAD SEC Filings 06/05/2015
Timber Pharmaceuticals, Inc. (TMBR) - CERTNAS SEC Filings 06/05/2015
Timber Pharmaceuticals, Inc. (TMBR) - S-1/A SEC Filings 06/01/2015
Timber Pharmaceuticals, Inc. (TMBR) - 8-A12B SEC Filings 06/01/2015
Timber Pharmaceuticals, Inc. (TMBR) - S-1/A SEC Filings 05/14/2015
Timber Pharmaceuticals, Inc. (TMBR) - CORRESP SEC Filings 05/14/2015
Timber Pharmaceuticals, Inc. (TMBR) - UPLOAD SEC Filings 05/06/2015
Timber Pharmaceuticals, Inc. (TMBR) - 8-K - Current report SEC Filings 05/01/2015
Timber Pharmaceuticals, Inc. (TMBR) - 4 SEC Filings 05/01/2015
Timber Pharmaceuticals, Inc. (TMBR) - SC 13G SEC Filings 04/21/2015
Timber Pharmaceuticals, Inc. (TMBR) - 10-KT - Current report SEC Filings 04/20/2015
Timber Pharmaceuticals, Inc. (TMBR) - S-1 SEC Filings 04/09/2015
Timber Pharmaceuticals, Inc. (TMBR) - 3/A SEC Filings 04/07/2015
Timber Pharmaceuticals, Inc. (TMBR) - 3 SEC Filings 04/01/2015
Timber Pharmaceuticals, Inc. (TMBR) - 8-K - Current report SEC Filings 03/30/2015
Timber Pharmaceuticals, Inc. (TMBR) - 10-K - Current report SEC Filings 03/30/2015
Timber Pharmaceuticals, Inc. (TMBR) - D/A SEC Filings 03/19/2015
Timber Pharmaceuticals, Inc. (TMBR) - D SEC Filings 03/19/2015
Timber Pharmaceuticals, Inc. (TMBR) - D SEC Filings 03/18/2015
Timber Pharmaceuticals, Inc. (TMBR) - DEF 14C SEC Filings 02/17/2015
Timber Pharmaceuticals, Inc. (TMBR) - 3 SEC Filings 02/13/2015
Timber Pharmaceuticals, Inc. (TMBR) - 3 SEC Filings 02/09/2015
Timber Pharmaceuticals, Inc. (TMBR) - PRE 14C SEC Filings 02/06/2015
Timber Pharmaceuticals, Inc. (TMBR) - 8-K - Current report SEC Filings 01/28/2015
Timber Pharmaceuticals, Inc. (TMBR) - S-8 SEC Filings 01/26/2015
Timber Pharmaceuticals, Inc. (TMBR) - 10-Q - Quarterly Report SEC Filings 11/14/2014
Timber Pharmaceuticals, Inc. (TMBR) - 8-K - Current report SEC Filings 11/12/2014
Timber Pharmaceuticals, Inc. (TMBR) - 10-Q - Quarterly Report SEC Filings 08/14/2014
Timber Pharmaceuticals, Inc. (TMBR) - 10-Q - Quarterly Report SEC Filings 05/15/2014
Timber Pharmaceuticals, Inc. (TMBR) - D SEC Filings 04/18/2014
Timber Pharmaceuticals, Inc. (TMBR) - 8-K - Current report SEC Filings 04/17/2014
Timber Pharmaceuticals, Inc. (TMBR) - 10-K - Current report SEC Filings 03/31/2014
Timber Pharmaceuticals, Inc. (TMBR) - 8-K - Current report SEC Filings 03/04/2014
Timber Pharmaceuticals, Inc. (TMBR) - SC 13D SEC Filings 02/18/2014
Timber Pharmaceuticals, Inc. (TMBR) - 3 SEC Filings 02/11/2014
Timber Pharmaceuticals, Inc. (TMBR) - SC 13D SEC Filings 02/04/2014
Timber Pharmaceuticals, Inc. (TMBR) - 3 SEC Filings 02/04/2014
Timber Pharmaceuticals, Inc. (TMBR) - SC 13D SEC Filings 01/31/2014
Timber Pharmaceuticals, Inc. (TMBR) - D SEC Filings 01/31/2014
Timber Pharmaceuticals, Inc. (TMBR) - 3 SEC Filings 01/30/2014
Timber Pharmaceuticals, Inc. (TMBR) - 8-K - Current report SEC Filings 01/27/2014
Timber Pharmaceuticals, Inc. (TMBR) - 10-K - Current report SEC Filings 12/31/2013
Timber Pharmaceuticals, Inc. (TMBR) - NT 10-K - Current report SEC Filings 12/30/2013
Timber Pharmaceuticals, Inc. (TMBR) - SC 14F1 SEC Filings 12/23/2013
Timber Pharmaceuticals, Inc. (TMBR) - SC 13D SEC Filings 12/13/2013
Timber Pharmaceuticals, Inc. (TMBR) - 3 SEC Filings 12/13/2013
Timber Pharmaceuticals, Inc. (TMBR) - 10-Q - Quarterly Report SEC Filings 08/16/2013
Timber Pharmaceuticals, Inc. (TMBR) - NT 10-Q - Quarterly Report SEC Filings 08/14/2013
Timber Pharmaceuticals, Inc. (TMBR) - 10-Q - Quarterly Report SEC Filings 05/15/2013
Timber Pharmaceuticals, Inc. (TMBR) - 10-Q - Quarterly Report SEC Filings 02/13/2013
Timber Pharmaceuticals, Inc. (TMBR) - 10-K - Current report SEC Filings 12/31/2012
Timber Pharmaceuticals, Inc. (TMBR) - 8-A12G SEC Filings 12/19/2012
Timber Pharmaceuticals, Inc. (TMBR) - 10-Q - Quarterly Report SEC Filings 08/13/2012
Timber Pharmaceuticals, Inc. (TMBR) - 10-Q - Quarterly Report SEC Filings 05/14/2012
Timber Pharmaceuticals, Inc. (TMBR) - 10-Q - Quarterly Report SEC Filings 02/14/2012
Timber Pharmaceuticals, Inc. (TMBR) - 10-K - Current report SEC Filings 01/13/2012
Timber Pharmaceuticals, Inc. (TMBR) - NT 10-K - Current report SEC Filings 12/29/2011
Timber Pharmaceuticals, Inc. (TMBR) - 10-Q/A - Quarterly Report SEC Filings 08/09/2011
Timber Pharmaceuticals, Inc. (TMBR) - 10-Q - Quarterly Report SEC Filings 08/09/2011
Timber Pharmaceuticals, Inc. (TMBR) - 10-Q - Quarterly Report SEC Filings 05/16/2011
Timber Pharmaceuticals, Inc. (TMBR) - 8-K - Current report SEC Filings 02/22/2011
Timber Pharmaceuticals, Inc. (TMBR) - 10-Q - Quarterly Report SEC Filings 02/18/2011
Timber Pharmaceuticals, Inc. (TMBR) - EFFECT SEC Filings 01/05/2011
Timber Pharmaceuticals, Inc. (TMBR) - 424B3 SEC Filings 01/05/2011
Timber Pharmaceuticals, Inc. (TMBR) - CORRESP SEC Filings 12/30/2010
Timber Pharmaceuticals, Inc. (TMBR) - UPLOAD SEC Filings 12/29/2010
Timber Pharmaceuticals, Inc. (TMBR) - UPLOAD SEC Filings 12/20/2010
Timber Pharmaceuticals, Inc. (TMBR) - S-1/A SEC Filings 12/20/2010
Timber Pharmaceuticals, Inc. (TMBR) - S-1/A SEC Filings 12/10/2010
Timber Pharmaceuticals, Inc. (TMBR) - S-1/A SEC Filings 11/24/2010
Timber Pharmaceuticals, Inc. (TMBR) - UPLOAD SEC Filings 11/22/2010
Timber Pharmaceuticals, Inc. (TMBR) - S-1 SEC Filings 10/27/2010

Press Releases

StockPrice Release
Timber pharmaceuticals, inc., a leo pharma company, presents late-breaking preliminary results of tmb-001 in moderate-to-severe congenital ichthyosis (ci) at the 2024 aad annual meeting 03/10/2024
Leo pharma finalizes acquisition of key assets from timber pharmaceuticals 01/23/2024
Timber pharmaceuticals announces commencement of nyse american delisting proceedings: common stock expected to begin trading on the otc market 11/29/2023
Timber pharmaceuticals announces commencement of nyse american delisting proceedings: common stock expected to begin trading on the otc market 11/29/2023
Timber pharmaceuticals receives court approval of all “first day” motions to support business operations & discloses communication from nyse american 11/28/2023
Nyse american to commence delisting proceedings against timber pharmaceuticals, inc. (tmbr) 11/21/2023
Timber pharmaceuticals announces nyse acceptance of plan to regain listing compliance 09/18/2023
Timber pharmaceuticals investor alert by the former attorney general of louisiana: kahn swick & foti, llc investigates timber pharmaceuticals, inc. - tmbr 08/29/2023
Tmbr stock alert: halper sadeh llc is investigating whether the sale of timber pharmaceuticals, inc. is fair to shareholders 08/21/2023
Leo pharma signs agreement to acquire timber pharmaceuticals 08/21/2023
Timber pharmaceuticals to be acquired by leo pharma 08/21/2023
Timber pharmaceuticals discloses communication from nyse american 07/03/2023
Timber pharmaceuticals announces fda grant of carc waiver for tmb-001 06/05/2023
Timber pharmaceuticals provides business update and announces fourth quarter and year end 2022 financial results 03/31/2023
Timber pharmaceuticals announces publication of sub-analysis of phase 2b control study in clinical and experimental dermatology 03/20/2023
Timber pharmaceuticals receives european orphan drug designation for tmb-001 in x-linked recessive ichthyosis 02/24/2023
Timber pharmaceuticals to host investor business briefing: milestone achievements and forward outlook 12/14/2022
Timber pharmaceuticals regains compliance with nyse american continued listing standards 12/09/2022
Timber pharmaceuticals provides business update and announces third quarter 2022 financial results 11/14/2022
Timber pharmaceuticals, inc. announces 1-for-50 reverse stock split 11/08/2022
Timber pharmaceuticals announces halt of common stock trading 11/03/2022
Timber pharmaceuticals receives european orphan designation for autosomal recessive congenital ichthyosis & positive comments on pediatric investigation plan for tmb-001 in autosomal recessive ci & x-linked recessive ichthyosis 10/25/2022
Timber pharmaceuticals announces $1.3 million registered direct offering 10/03/2022
Timber pharmaceuticals receives positive opinion on orphan designation from european medicines agency for tmb-001 for treatment of autosomal recessive congenital ichthyosis 09/14/2022
Timber pharmaceuticals announces notification of nyse american continued listing deficiency 08/29/2022
Timber pharmaceuticals to highlight phase 2b control study results in multiple presentations at 31st eadv congress 08/29/2022
Timber pharmaceuticals announces publication of results from phase 2b control study of fda-designated breakthrough therapy tmb-001 in the journal of the american academy of dermatology 08/26/2022
Timber pharmaceuticals provides business update and announces second quarter 2022 financial results 08/11/2022
Timber pharmaceuticals announces pricing of $8.0 million public offering 08/04/2022
Timber pharmaceuticals announces first patients enrolled in phase 3 ascend clinical trial evaluating tmb-001 in congenital ichthyosis 06/23/2022
Timber pharmaceuticals receives fda breakthrough therapy designation for tmb-001 for the treatment of congenital ichthyosis 05/31/2022
Timber pharmaceuticals provides business update and announces first quarter 2022 financial results 05/12/2022
Timber pharmaceuticals announces fast track designation granted by fda for tmb-001 in severe subtypes of congenital ichthyosis 04/28/2022
Timber pharmaceuticals provides business update and announces fourth quarter and year end 2021 financial results 03/31/2022
Timber pharmaceuticals announces late-breaking presentation at the american academy of dermatology 2022 annual meeting 03/25/2022
Timber pharmaceuticals: invitation to the q1 virtual investor summit 02/28/2022
Timber pharmaceuticals announces positive end-of-phase 2 meeting with fda for tmb-001 in moderate to severe congenital ichthyosis 02/03/2022
Timber pharmaceuticals to present at h.c. wainwright bioconnect conference 01/06/2022
Timber pharmaceuticals to host conference call discussing positive topline results from phase 2b control study of congenital ichthyosis for lead asset, tmb-001 11/17/2021
Timber pharmaceuticals provides business update and announces third quarter 2021 financial results 11/15/2021
Timber pharmaceuticals announces closing of $15 million public offering 11/05/2021
Timber pharmaceuticals announces pricing of $15 million public offering 11/03/2021
Timber pharmaceuticals announces proposed public offering 11/02/2021
Timber pharmaceuticals reports positive top-line results from phase 2b control study evaluating tmb-001 in moderate to severe congenital ichthyosis 10/07/2021
Timber pharmaceuticals to present at the h.c. wainwright 23rd annual global investment conference 09/10/2021
Timber pharmaceuticals announces last patient last visit in phase 2b control study evaluating tmb-001 in moderate to severe congenital ichthyosis 08/24/2021
Timber pharmaceuticals announces adjournment of annual meeting 06/03/2021
Timber pharmaceuticals announces completion of patient enrollment in phase 2b control study evaluating tmb-001 in congenital ichthyosis 05/26/2021
Timber pharmaceuticals provides business update and announces first quarter 2021 financial results 05/11/2021
Timber pharmaceuticals announces appointment of john koconis as chairman of the board of directors 04/23/2021
Timber pharmaceuticals sets record date for annual meeting of shareholders and provides update on its annual filings 04/02/2021
Timber pharmaceuticals provides business update and announces year end 2020 financial results 03/23/2021
Timber pharmaceuticals' development partner, aft pharmaceuticals, enters into licensing agreement for pascomer® (tmb-002) in europe 03/17/2021
Timber pharmaceuticals announces 50% enrollment in phase 2b control study in congenital ichthyosis 03/15/2021
Timber pharmaceuticals announces presentation at 2021 h.c. wainwright global life sciences conference 03/05/2021
Timber pharmaceuticals appoints alan mendelsohn, m.d., as chief medical officer 01/25/2021
Timber pharmaceuticals receives orphan drug designation from u.s. fda for tmb-003 for the treatment of systemic sclerosis 01/12/2021
Timber pharmaceuticals hosts business update conference call 12/10/2020
Timber pharmaceuticals expect to complete enrollment of patients in both tmb-001 and tmb-002 studies during early months of 2021 08/18/2020
Biopharmx corp's david tierney steps down as ceo 02/03/2020
Biopharmx reports third-quarter loss per share of 14 cents 12/10/2019

More Headlines

News
Timber Pharmaceuticals Announces NYSE Acceptance of Plan to Regain Listing Compliance WARREN, NJ, Sept. 18, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Timber Pharmaceuticals, Inc. ("Timber" or the “Company”) (NYSE American: TMBR), a clinical-stage biopharmaceutical company focused on the development and commercialization of treatments for rare and orphan dermatologic diseases, today announced that the NYSE American LLC (the “NYSE American”) has accepted the Company's business plan to regain compliance with the continued listing standards set forth in Sections 1003(a)(i) and (ii) of the NYSE American Company Guide. 09/18/2023
TIMBER PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Timber Pharmaceuticals, Inc. - TMBR NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Timber Pharmaceuticals, Inc. (“the Company”) (NYSE: TMBR) to LEO Pharma A/S. KSF is seeking to determine whether the transaction and the process that led to it are adequate and fair to the Company's shareholders. If you would like to discuss your legal rights regarding the proposed sale, you may, without oblig. 08/29/2023
Timber (TMBR) to Get Acquired by LEO Pharma for $36M, Stock Up Timber (TMBR) surges as LEO Pharma offers to acquire it for approximately $36 million. 08/22/2023
TMBR Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Timber Pharmaceuticals, Inc. Is Fair to Shareholders NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Timber Pharmaceuticals, Inc. (NYSE: TMBR) to LEO Pharma A/S is fair to Timber shareholders. Halper Sadeh encourages Timber shareholders to click here to learn more about their legal rights and options or contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or sadeh@halpersadeh.com or zhalper@halpersadeh.com. The investigation concerns whether Timber and its board of directors viola. 08/21/2023
Why Is Timber Pharmaceuticals (TMBR) Stock Up 96% Today? Timber Pharmaceuticals (NYSEMKT: TMBR ) stock is undergoing a massive rally on Monday after announcing that Leo US is acquiring it in a $36 million deal. According to a press release from Timber Pharmaceuticals, that acquisition has an upfront payment of $14 million for TMBR stock. 08/21/2023
LEO Pharma Signs Agreement to Acquire Timber Pharmaceuticals BALLERUP, Denmark--(BUSINESS WIRE)--LEO Pharma Signs Agreement to Acquire Timber Pharmaceuticals. 08/21/2023
Timber Pharmaceuticals to be Acquired by LEO Pharma WARREN, NJ, Aug. 21, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire -- Timber Pharmaceuticals, Inc. (“Timber” or the “Company”) (NYSE American: TMBR) today announced that it has entered into a definitive agreement to be acquired by LEO US Holding, Inc. (“LEO Pharma”), a wholly-owned subsidiary of LEO Pharma A/S, in a total transaction value of up to $36 million with (i) an initial upfront consideration of $14 million and (ii) up to an additional $22.0 million in contingent value rights (CVRs) payable upon achievement of certain milestones described below. All of the issued and outstanding shares of capital stock and other equity interests of Timber will be converted into the right to receive the initial upfront consideration, less the payments for certain outstanding warrants that contain a Black Scholes cash payout value. For example, based on a current estimate of the Black Scholes value of such warrants of approximately $5.1 million, subject to change based on the assumptions detailed below, Timber expects the initial amount per share to be paid to Timber stockholders to be approximately $2.62 based on approximately 3.4 million shares of Timber common stock and restricted stock issued and outstanding as of August 20, 2023. 08/21/2023
Timber Pharmaceuticals Discloses Communication From NYSE American WARREN, NJ, July 03, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Timber Pharmaceuticals, Inc. ("Timber" or the “Company”) (NYSE American: TMBR), a clinical-stage biopharmaceutical company focused on the development and commercialization of treatments for rare and orphan dermatologic diseases, today announced that on June 28, 2023 it received a letter (the “Notice”) from the NYSE American LLC (“NYSE American” or the “Exchange”) advising the Company is not in compliance with the NYSE American continued listing standards set forth in Sections 1003(a)(i) and (ii) of the NYSE American Company Guide given the reported stockholders' deficit as of March 31, 2023, and losses from continuing operations and/or net losses in its four most recent fiscal years then ended. 07/03/2023
Timber (TMBR) Surges on Carcinogenicity Waiver for TMB-001 Timber (TMBR) receives a dermal carcinogenicity waiver from the FDA for TMB-001, which is being developed to treat moderate-to-severe subtypes of congenital ichthyosis. 06/08/2023
Bears are Losing Control Over Timber Pharmaceuticals, Inc. (TMBR), Here's Why It's a 'Buy' Now Timber Pharmaceuticals, Inc. (TMBR) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term. 04/14/2023
Building a Penny Stocks Portfolio For Long Term Use these tips for buying penny stocks for the long term The post Building a Penny Stocks Portfolio For Long Term appeared first on Penny Stocks to Buy, Picks, News and Information \| PennyStocks.com. 02/27/2023
Penny Stock Investing: How to Analyze Market Conditions Use these tips to analyze penny stocks The post Penny Stock Investing: How to Analyze Market Conditions appeared first on Penny Stocks to Buy, Picks, News and Information \| PennyStocks.com. 02/26/2023
Why Is Timber Pharmaceuticals (TMBR) Stock Up 61% Today? Timber Pharmaceuticals (NYSEMKT: TMBR ) stock is taking off on Friday after getting an orphan drug designation in Europe. That comes from the EC and covers TMB-001 for the treatment of X-linked recessive ichthyosis. 02/24/2023
Top Penny Stocks To Buy? 4 For Your Watch List Before Next Week Penny stocks under $1 to watch this week. The post Top Penny Stocks To Buy? 08/25/2022
Best Penny Stocks to Buy Now? 3 For Your August List Here's what you need to know about trading penny stocks on August 10th The post Best Penny Stocks to Buy Now? 3 For Your August List appeared first on Penny Stocks to Buy, Picks, News and Information \| PennyStocks.com. 08/10/2022
Best Penny Stocks to Buy Under $1? 3 to Watch as April Ends Are these under $1 penny stocks on your watchlist? The post Best Penny Stocks to Buy Under $1? 04/28/2022
Timber Pharmaceuticals to Present at H.C. Wainwright BioConnect Conference Virtual Conference on January 10-13, 2022 01/06/2022
Timber Pharmaceuticals to Host Conference Call Discussing Positive Topline Results from Phase 2b CONTROL Study of Congenital Ichthyosis for Lead Asset, TMB-001 Call to be held on Monday, November 22nd at 10:00am ET 11/17/2021
TMBR Stock: Why The Price Plummeted Today The stock price of Timber Pharmaceuticals Inc (NYSEAMERICAN: TMBR) fell by over 33% during intraday trading today. This is why it happened. 11/03/2021
Timber Pharmaceuticals Reports Positive Top-line Results from Phase 2b CONTROL Study Evaluating TMB-001 in Moderate to Severe Congenital Ichthyosis Basking Ridge, NJ, Oct. 07, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Timber Pharmaceuticals, Inc. ("Timber" or the “Company”) (NYSE American: TMBR), a biopharmaceutical company focused on the development and commercialization of treatments for rare and orphan dermatologic diseases, today announced positive top-line data from its Phase 2b CONTROL study evaluating TMB-001, an investigational topical isotretinoin formulated using Timber's patented IPEG™ delivery system, in patients with moderate to severe congenital ichthyosis (CI). 10/07/2021
Timber Pharmaceuticals to Present at the H.C. Wainwright 23rd Annual Global Investment Conference BASKING RIDGE, NJ, Sept. 10, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire – Timber Pharmaceuticals, Inc. ("Timber" or the “Company”) (NYSE American: TMBR), a biopharmaceutical company focused on the development and commercialization of treatments for rare and orphan dermatologic diseases, today announced that it will present at the H.C. Wainwright 23rd Annual Global Investment Conference. The Conference will be held virtually with all participants joining remotely from September 13th - 15th, 2021. 09/10/2021
Timber Pharmaceuticals Announces Last Patient Last Visit in Phase 2b CONTROL Study Evaluating TMB-001 in Moderate to Severe Congenital Ichthyosis - Topline results expected to be announced in the fourth quarter of 2021 - 08/24/2021
Best Penny Stocks to Buy Now? 3 to Watch This Week Are these top penny stocks worth watching right now? The post Best Penny Stocks to Buy Now? 08/22/2021
7 Hottest Penny Stocks to Pick Up Now Penny stocks from companies that have reasonable business fundamentals. Stocks that can possibly provide multi-fold returns. 08/10/2021
7 Reddit Penny Stocks to Watch for Big Upside Ahead If we've learned anything from the Reddit in January, it's not to underestimate them. These 7 Reddit penny stocks have good upsides. 06/28/2021
Timber Pharmaceuticals Announces Adjournment of Annual Meeting Basking Ridge, NJ, June 03, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Timber Pharmaceuticals, Inc. ("Timber" or the “Company”) (NYSE American: TMBR), a biopharmaceutical company focused on the development and commercialization of treatments for rare and orphan dermatologic diseases, today announced that on June 3, 2021 its 2021 Annual Meeting of Stockholders (the “Annual Meeting”) was convened without a quorum. As a result, in order to provide stockholders additional time within which to vote their eligible shares to establish a quorum, the Annual Meeting was adjourned. 06/03/2021
Timber Pharmaceuticals Announces Completion of Patient Enrollment in Phase 2b CONTROL Study Evaluating TMB-001 in Congenital Ichthyosis - Company plans to ask for end-of-Phase 2 meeting with FDA by end of 2021 - 05/26/2021
Investing in Penny Stocks? Don't Before You Do These 3 Things Before investing in penny stocks, take a look at these 3 things The post Investing in Penny Stocks? Don't Before You Do These 3 Things appeared first on Penny Stocks to Buy, Picks, News and Information \| PennyStocks.com. 05/11/2021
Timber Pharmaceuticals Provides Business Update and Announces First Quarter 2021 Financial Results BASKING RIDGE, NJ, May 11, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Timber Pharmaceuticals, Inc. ("Timber" or the “Company”) (NYSE American: TMBR), a biopharmaceutical company focused on the development and commercialization of treatments for rare and orphan dermatologic diseases, today provided a business update and announced financial results for the first quarter ended March 31, 2021. 05/11/2021
7 Reddit Penny Stocks to Buy for a Biotech Boom So, which biotech penny stocks, popular with the Reddit set, offer such opportunity? Consider these seven as ones with potential to live up to online enthusiasm. 04/16/2021
5 Reddit Penny Stocks Seeing the Most Chatter Thursday It's never a dull day on the Reddit Penny Stocks subreddit and we're checking in to see what's being talked about the most today. The post 5 Reddit Penny Stocks Seeing the Most Chatter Thursday appeared first on InvestorPlace. 04/15/2021
DISCB and 6 Other Reddit Stocks Waiting for a Short Squeeze Reddit stocks continue to have the public's attention. These 7 could be the next short squeeze targets based on technical signs. 04/07/2021
Timber Pharmaceuticals Sets Record Date for Annual Meeting of Shareholders and Provides Update on Its Annual Filings Basking Ridge, NJ, April 02, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Timber Pharmaceuticals, Inc. (NYSE American: TMBR) ("Timber” or the "Company"), a biopharmaceutical company focused on the development and commercialization of treatments for rare and orphan dermatologic diseases, today announced that its Annual Meeting of Shareholders will be held at 1:00 pm EDT on Thursday, June 3, 2021 (the “Annual Meeting”). The Company has established April 12, 2021 as the record date for the Annual Meeting. 04/02/2021
Timber Pharmaceuticals Provides Business Update and Announces Year End 2020 Financial Results 50% of patients in the Phase 2b CONTROL study have now been randomized despite COVID-19 disruptions in the trial marketplace 03/23/2021
Timber Pharmaceuticals' Development Partner, AFT Pharmaceuticals, Enters into Licensing Agreement for Pascomer® (TMB-002) in Europe - Extension of agreement with AFT Pharmaceuticals grants Desitin Arzneimittel GmbH exclusive license and supply rights for TMB-002 in Europe - 03/17/2021
Timber Pharmaceuticals Announces 50% Enrollment in Phase 2b CONTROL Study in Congenital Ichthyosis - Study is Evaluating TMB-001 (Topical Isotretinoin) in Subtypes of Rare Genetic Keratinization Disorder 03/15/2021
TMBR Stock Price Increased 71.14%: What You Should Know About The Company The stock price of Timber Pharmaceuticals Inc (NYSEAMERICAN: TMBR) increased by 71.14% today. This is what you should know about the company. 03/11/2021
TMBR Stock: What to Know About Red-Hot Timber Pharmaceuticals Timber Pharmaceuticals spiked more than 75% in trading today following a virtual life sciences conference this week. Trading volume in TMBR stock was up more than 1600% on the day. 03/11/2021
Timber Pharmaceuticals Announces Presentation at 2021 H.C. Wainwright Global Life Sciences Conference WOODCLIFF LAKE, N.J., March 05, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Timber Pharmaceuticals, Inc. ("Timber" or the “Company”) (NYSE American: TMBR), a biopharmaceutical company focused on the development and commercialization of treatments for rare and orphan dermatologic diseases, today announced that Timber's Chief Executive Officer John Koconis will present a corporate overview at the virtual 2021 H.C. Wainwright Global Life Sciences Conference being held on March 9-10, 2021. 03/05/2021
7 Penny Stocks In a Make-or-Break Year These penny stocks are companies that have a crucial year ahead in terms of industry turnaround or company specific product development. The post 7 Penny Stocks In a Make-or-Break Year appeared first on InvestorPlace. 02/24/2021
Timber Pharmaceuticals Appoints Alan Mendelsohn, M.D., as Chief Medical Officer Dr. Mendelsohn has 20+ Years' Experience in Clinical Development and Medical Affairs 01/25/2021
Timber Pharmaceuticals Receives Orphan Drug Designation from U.S. FDA for TMB-003 for the Treatment of Systemic Sclerosis Timber Expects to Submit Investigational New Drug (IND) Application to the FDA in 2022 01/12/2021
Timber Pharmaceuticals Hosts Business Update Conference Call Call to be held on Thursday, December 17th at 11:00am EST 12/10/2020

Unlock

TMBR Ratings Summary

TMBR Quant Ranking